BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8873164)

  • 1. Alternative therapies for children with brain stem gliomas: immunotherapy and gene therapy.
    Packer RJ
    Pediatr Neurosurg; 1996; 24(4):217-22. PubMed ID: 8873164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II study.
    Packer RJ; Prados M; Phillips P; Nicholson HS; Boyett JM; Goldwein J; Rorke LB; Needle MN; Sutton L; Zimmerman RA; Fitz CR; Vezina LG; Etcubanas E; Wallenberg JC; Reaman G; Wara W
    Cancer; 1996 May; 77(10):2150-6. PubMed ID: 8640684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-beta gene therapy for malignant glioma in an experimental mouse intracranial glioma.
    Saito R; Mizuno M; Nakahara N; Tsuno T; Kumabe T; Yoshimoto T; Yoshida J
    Int J Cancer; 2004 Sep; 111(5):777-82. PubMed ID: 15252850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glioma].
    Wakabayashi T; Natsume A; Yoshida J
    Nihon Rinsho; 2006 Jul; 64(7):1327-32. PubMed ID: 16838652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brainstem gliomas.
    Packer RJ; Nicholson HS; Vezina LG; Johnson DL
    Neurosurg Clin N Am; 1992 Oct; 3(4):863-79. PubMed ID: 1392581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapies for malignant gliomas.
    Cavaliere R; Wen PY; Schiff D
    Neurol Clin; 2007 Nov; 25(4):1141-71, x. PubMed ID: 17964029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunobiology and immunotherapeutic targeting of glioma stem cells.
    Madany M; Thomas TM; Edwards L; Yu JS
    Adv Exp Med Biol; 2015; 853():139-66. PubMed ID: 25895711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain stem gliomas: therapeutic options at time of recurrence.
    Rekate HL
    Pediatr Neurosurg; 1996 Oct; 25(4):220. PubMed ID: 9293549
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy for glioma: Current management and future application.
    Xu S; Tang L; Li X; Fan F; Liu Z
    Cancer Lett; 2020 Apr; 476():1-12. PubMed ID: 32044356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric brain stem gliomas: an update.
    Rubin G; Michowitz S; Horev G; Herscovici Z; Cohen IJ; Shuper A; Rappaport ZH
    Childs Nerv Syst; 1998; 14(4-5):167-73. PubMed ID: 9660117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of emerging therapy in the management of patients with diffuse low grade glioma.
    Sloan AE; Okada H; Ryken TC; Kalkanis SN; Olson JJ
    J Neurooncol; 2015 Dec; 125(3):631-5. PubMed ID: 26530260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Immunotherapy for Gliomas: Overview and Future Directions.
    Hashimoto N
    Neurol Med Chir (Tokyo); 2016 Jul; 56(7):355-60. PubMed ID: 27087194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic glioma of the brain stem with prolonged survival.
    Soffer D; Sahar A
    Neurosurgery; 1982 Apr; 10(4):499-502. PubMed ID: 7099400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression levels of Fas/Fas-L mRNA in human brain glioma stem cells.
    Tao J; Qiu B; Zhang D; Wang Y
    Mol Med Rep; 2012 May; 5(5):1202-6. PubMed ID: 22344564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target.
    Carpenter CD; Alnahhas I; Gonzalez J; Giglio P; Puduvalli VK
    Expert Rev Neurother; 2019 Jul; 19(7):663-677. PubMed ID: 31106606
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficient transfection of human interferon-beta gene to human glioma cells by means of cationic multilamellar liposomes coupled with a monoclonal antibody [corrected].
    Yoshida J; Mizuno M; Yagi K
    J Neurooncol; 1994; 19(3):269-74. PubMed ID: 7807178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral gliomas: how tumor biology affects management.
    Piepmeier JM
    Clin Neurosurg; 2001; 48():3-9. PubMed ID: 11692648
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effectiveness of interferon-beta against glioma cells and its augmentation of growth inhibitory effect by transfection of its gene].
    Wakabayashi T; Mizuno M; Yoshida J
    Hum Cell; 1995 Sep; 8(3):95-8. PubMed ID: 8652452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma.
    Deng S; Zhu S; Qiao Y; Liu YJ; Chen W; Zhao G; Chen J
    Protein Cell; 2014 Dec; 5(12):899-911. PubMed ID: 25411122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.